Reveal Biosensors, Inc. engages in the development of Cellular Energy monitor. It provides new measurement of human physiology which helps in heart rate and pulse oximeter vital sign information. The company was founded by Steve Ursenbach and Guy Hatch and is headquartered in San Diego, CA.

Tokyo Metropolitan Institute of Medical Science is a Japanese private company. The firm operates as a research institute that develops medicine.

Bionaut Pharmaceuticals is a biotechnology company that discovers and advances small molecule drug candidates. The company’s Sentinel Pathway Reporter System has product driven applications, such as initiation and development of drug discovery programs, identifying biomarkers for clinical trials, validating existing drug candidates for a specific disease pathway, and identifying new indications for existing drug candidates and known drugs; and research-driven applications, including deciphering pathways and their relationships, and identifying genes. Bionaut Pharmaceuticals was founded in 2000 and is based in Cambridge, Massachusetts.

Yuxi China Tobacco Seeds Co., Ltd., established on 2001-08-15, Business scope includes licensed projects:Crop Seed Management(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;production of agricultural products,Sales,processing,transportation,Storage and other related services;Crop pest control services;Synthetic Materials Sales;Mechanical equipment research and development;Machinery sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Dalian Tianxing Biotechnology Co., Ltd., established on 2015-06-12, Business scope includes licensed projects:Class III medical device business,Inspection and testing service,Technology Import and Export,Sales of formula food for special medical purposes,food business,Health food sales,Food Internet Sales,Food import and export,Import and export agency(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Medical Research and Experimental Development,R&D and application of cell technology,Human stem cell technology development and application,Development of Human Gene Diagnosis and Therapy Technology,Research and development of bio-based materials technology,Sales of bio-based materials,Sales of Class I Medical Devices,Sales of Class II Medical Devices,Health Consulting Services(Does not include medical services),Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Sales of hygiene products and single-use medical products,Cosmetics Wholesale,Cosmetics Retail,Sales of special labor protection products,Domestic trade agent(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shanghai East Hospital is a Chinese private company located in Shanghai. The firm operates hospital.

Manufactures pharmaceuticals

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Geneva, Switzerland.

Immuno-Biological Laboratories Co., Ltd. engages in the manufacture and sale of antibody-related reagents and pharmaceutical products. It operates through the following segments: Diagnostics and Reagents, Genetically Modified Silkworm, Testing, and Cosmetics-related. The Diagnostics and Reagents segment deals with the research and development of reagents and pharmaceutical products as well as in vitro diagnostic pharmaceuticals. The Genetically Modified Silkworm segment sells products using the cocoon of genetically modified silkworm. The Testing segment offers prevention and diagnostic support on top of drug discovery and research support in lifestyle-related diseases using lipid metabolism analysis technology. The Cosmetics-related segment develops and manufactures cosmetic products containing Neosilk-Human Collagen I. The company was founded on September 9, 1982 and is headquartered in Fujioka, Japan.